Glycom receives Novel Food status for HMO blend
date:Dec 05, 2019
The EU Commission (EC) has granted Novel Food status to Danish biotechnology company Glycom for its 2-Fucosyllactose/Difucosyllactose mixture (2-FL/DFL). Having received the European Food Safety Authoritys (EFSA) recommendation, the EC concluded that the 2-FL/DFL blend is safe for consumption in certain applications. With this greenlight, Glycom can now use this Human Milk Oligosaccharide (HMO) in a variety of uses on the EU market, including as a dietary supplement and in infant formula.

We a
1/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/04 06:39